Diabetes Flashcards

1
Q

Typical presentation of DM1? (3)

A

DKA (d/t unaware of condition)
weight loss
Eyesight issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Treatment Strategy for DM1? (2)

A

INSULIN (always)

+/- Pramlintide (symlin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the role of Pramlintide in treatment of diabetes?

A

Reduces gastric emptying, which reduces postprandial BS peaks/spikes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a major risk of taking Pramlintide?

A

Hypoglycemia (warn patient self monitor for symptoms 3 hours after administration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What medication adjustment must be made in an insulin dependent diabetic who begins taking Pramlintide?

A

Insulin dose MUST be reduced by 50%

**Pramlintide Can not be combined with insulin in the syringe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Side effects of Pramlintide? (3)

A

Nausea and vomiting (r/t slowed gastric emptying/overeating)
Diarrhea
Hypoglycemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Contrindication for Pramlintide

A

DM related gastropheresis (already slowed emptying compounded and can cause complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Defining characteristics of DM1? (2)

A

Autoimmune

Characterized by relative or absolute lack of insulin (beta cells in pancreas destroyed)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Defining characteristics of DM2? (3)

A

Metabolic Disorder
Body cannot make enough, or properly use insulin
Can lead to the eventual destruction of beta cells in pancreas (leading to insulin dependence)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is important to know about Gestational diabetes? (3)

A

Diagnosed in 2nd or 3rd trimester
Usually seen in pts who did not have diabetes prior to pregnancy
Require TIGHT control of blood sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Diabetes treatment considerations in patients with HIV? (1)

A

Screen for pre-diabets and DM prior to starting ART (protease inhibitors)

If normal, screen yearly
If pre-diabetic, repeat every 3-6 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What suffix do most Portease Inhibitors end in?

A

-VIER

Used in treatment of HIV and have implications in development of DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What drugs are primarily associated with drug-induced DM? (3)

A

Glucocorticoids
Anti-retrovirals for HIV (protease inhibitors)
Anti-rejection drugs (post transplant)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of Insulin in the body?

A

Insulin reduces blood glucose levels in the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the typical clinical presentation in DM2? (6)

A
Polyuria (increased urination)
Polyphagia (increased hunger)
Polydipsia (increased thirst)
Weight changes (often weight gain in T2, weight loss T1 but not always)
Changes in vision
Changes in sensory function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Who should be screened for Diabetes? (2)

A
Adults >45, regardless of weight
Overweight Adults (BMI >25) or obese with 1 or more risk factors for DM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Diagnostic criteria for Pre-Diabetes? (3)

A

A1C 5.7-6.4%
Fasting (8 hours) Glucose 100-125
2-hour post load glucose 140-199 during OGTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Diagnostic criteria for DM? (4)

A
A1C > 6.5%
Symptoms plus:
Random glucose >200
Fasting (8 hours) Glucose >126
2-Hour Post load glucose >200 during OGTT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Factors that impact A1C independent of glycemia? (4)

A

Sickle Cell (0.3% lower)
G6PD (0.7-0.8% lower)
HIV
CKD with hemodialysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the treatment strategy for DM2? (4)

A

Medical Nutrition Therapy (MNT) + physical activity
Monotherapy or combination therapy
Addition of Insulin (basal or long-acting)
Evaluation and management of other metabolic complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Primary action of Secretagogue Medications?

A

Increase insulin secretion from beta cells

THESE CAUSE PROGRESSION OF DM by burning out the beta cells

22
Q

What are 3 primary negative effects of secretagogue medications?

A

THESE CAUSE PROGRESSION OF DM by burning out the beta cells

Weight Gain

Severe Hypoglycemia

23
Q

What are the 2 classes of secretagogues?

A

Meglitinides

Sulfonylureas

24
Q

MOA of Meglitinides?

A

Stimulate insulin release from the beta cells in the pancreas

25
Q

What has longer duration of action, Meglitinides or Sulfonylureas?

A

Sulfonylureas-can be given once daily

26
Q

Name 2 Meglitinides

A

Repaglinide (Prandin)

Nateglinide (Starlix)

27
Q

What suffix do most Meglitinides end in?

A

-GLINIDE

28
Q

DDI with Repaglinide (Prandin)? (5)

A
Gefibrozil
Itraconazole
Clopidogrel (Plavix)
Cyclosporine
Atazanavir (protease inhibitor for HIV treatment)
29
Q

What drug is Repaglinide (Prandin) often combined with?

A

Metformin

30
Q

Dosing consideration for Nateglinide (Starlix)? (1)

A

Must be given before meals

31
Q

MOA Sulfonylureas?

A

Stimulate insulin release from pancreatic beta cells

+/- reduces hepatic glucose output

32
Q

How are second generation Sulfonylureas dosed?

A

Before each meal

33
Q

Give drug names for second 2nd Generation Sulfonylureas? (3)

A

Glimepiride
Glipizide
Glyburide

34
Q

What drug classes are

Non-Secretagogues? (6)

A
Alpha-glucosidase Inhibitors
Biguanides
DDP-4 Inhibitors
GLP-1 Agonists
SGLT2 Inhibitors
TZD
35
Q

What is the primary function of non-secretagogues?

A

Augment pancreatic insulin

36
Q

MOA of Alpha-glucosidase inhibitors?

A

Delay breakdown of complex carbs and absorption of glucose (work within GI
Tract)

*SLOWS carb digestion and absorption, helping to minimize post-prandial BS spikes

37
Q

How must Alpha-glucosidase inhibitors be dosed?

A

MUST be given with meals (with first bite of food)

38
Q

SE of Alpha-glucosidase inhibitors?

A

GI issues

39
Q

Give drug names for Alpha-glucosidase inhibitors? (2)

A

Acarbose

Miglitol

40
Q

Benefits of alpha-glucosidase inhibitors as a class? (2)

A

No weight gain

No hypoglycemia

41
Q

What effect do alpha-glucosidase inhibitors have on Hbg A1C?

A

Modest reductions (0.5-1%)

42
Q

MOA of Biguanides?

A

Reduce hepatic glucose production (reducing fasting glucose levels)

43
Q

Side effects of biguanides? (2)

A

GI issues

Lactic Acidosis

44
Q

Clinical benefits of Biguanides?

A
Weight loss
No Hypoglycemia
Improves Insulin Resistance 
Low Cost
Can improve lipid-profile
       -decrease FA & VLDL synthesis from 
        liver, decreasing TG
45
Q

Drug names for Biguanides?

A

Metformin

46
Q

What is the maximum dose for Metformin?

A

2g/day
Can be in divided doses
The higher the dose, the more side effects

47
Q

Contraindications of Metformin? (4)

A

Moderate to severe liver disease
Chronic/Binge ETOH
Pregnancy
Breast Feeding

48
Q

If a patient is taking Metformin, when does the medication need to be held?

A

Renal Failure
Surgery
Anything that may involve IV contrast (stop day of an don’t resume for 48 hours), more of an issue in AKI and risk of higher load contrast

49
Q

What is the effect of Metformin on Hbg A1C?

A

Reduction of 1.5-2.0%

50
Q

Warnings/cautions for use of Metformin? (2)

Address renal dosing (yes or no)

A

Moderate to severe liver disease
Renal Dose adjustments required
Don’t give metformin if GFR <30
Evaluate risk vs benefit if GFR <45